Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

Fig. 2

AVX235 inhibits tumor growth. 30 mg/kg AVX235 or vehicle (DMSO) alone was injected i.p. in MAS98.12 mice (daily for the first week, then every second day). The mean normalized tumor volumes are shown as black dots for control tumors (n = 10) and grey triangles for treated tumors (n = 11). Error bars represent the standard errors of the means. * p < 0.05, two-tailed Mann–Whitney U test, control vs. treated group on the same day

Back to article page